Check-Cap and MBody AI Merger Progress Update
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy MBAI?
Source: Newsfilter
- Nasdaq Application Submission: MBody AI's submission of its Nasdaq listing application represents a significant regulatory milestone toward the merger with Check-Cap, with a target completion in the first half of 2026, further advancing the combined company's path to Nasdaq Capital Markets.
- Compliance Restoration: Check-Cap has recently regained compliance with Nasdaq continued listing requirements and filed a Form F-1 Registration Statement related to its equity line of credit facility with ARC Group International Inc., demonstrating steady progress in the merger process.
- Completion of Financial Audits: MBody AI's audited financial statements as of December 31, 2024, and for the six months ended June 30, 2025, have been furnished, further accelerating the merger process and enhancing investor confidence.
- Positive Future Outlook: Executives from both companies express strong confidence in the prospects of the merger, with MBody AI's CEO emphasizing its central position in the physical AI space, anticipating increased interest from public market investors.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MBAI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MBAI
About MBAI
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Nasdaq Application Submission: MBody AI's submission of its Nasdaq listing application represents a significant regulatory milestone toward the merger with Check-Cap, with a target completion in the first half of 2026, further advancing the combined company's path to Nasdaq Capital Markets.
- Compliance Restoration: Check-Cap has recently regained compliance with Nasdaq continued listing requirements and filed a Form F-1 Registration Statement related to its equity line of credit facility with ARC Group International Inc., demonstrating steady progress in the merger process.
- Completion of Financial Audits: MBody AI's audited financial statements as of December 31, 2024, and for the six months ended June 30, 2025, have been furnished, further accelerating the merger process and enhancing investor confidence.
- Positive Future Outlook: Executives from both companies express strong confidence in the prospects of the merger, with MBody AI's CEO emphasizing its central position in the physical AI space, anticipating increased interest from public market investors.
See More
- Nasdaq Listing Application: MBody AI's submission of its Nasdaq listing application represents a significant regulatory milestone toward the merger with Check-Cap, with a target completion in the first half of 2026, further advancing the combined company's path to public listing.
- Compliance Restoration: Check-Cap has regained compliance with Nasdaq continued listing requirements and filed a Form F-1 Registration Statement related to its equity line of credit facility with ARC Group International Inc., demonstrating positive progress in the merger process.
- Completion of Financial Audits: MBody AI has furnished audited financial statements as of December 31, 2024, indicating financial transparency and compliance prior to the merger, which enhances investor confidence.
- Optimistic Market Outlook: Executives from both companies express strong confidence in the future post-merger, believing that the merger will position them as leaders in the rapidly growing embodied AI market, attracting more public market investors.
See More
- Merger Progress: Check-Cap Ltd. announced significant advancements in its merger with MBody AI Corp., having filed a Form F-1 Registration Statement and provided MBody AI's audited financials, with the merger expected to close in the first half of 2026, marking a crucial step following the company's return to Nasdaq compliance.
- Enhanced Capital Flexibility: The Form F-1 registration allows Check-Cap to access up to $30 million in discretionary growth capital through an equity line of credit with ARC Group International Inc., which will provide strategic flexibility for scaling MBody AI's commercial platform post-merger.
- Financials Reflect Platform-Building Phase: The audited financials from MBody AI indicate a platform-building phase for the years ended December 31, 2024, and June 30, 2025, with expectations of significant customer deployment growth in the second half of 2025, signaling a transition to a new phase of commercial scale.
- Positive Leadership Outlook: David Lontini, Chairman and Interim CEO of Check-Cap, emphasized that completing the merger will position the company as a leader in physical AI, enhancing financial flexibility and preparing for future market opportunities.
See More
- Compliance Restored: Check-Cap Ltd. announced its return to compliance with Nasdaq listing requirements, marking a significant step forward in the merger process with MBody AI, which is expected to close in the first half of 2026, enhancing market confidence in the company.
- Increased Financial Flexibility: The filed Form F-1 Registration Statement enables the company to access up to $30 million in discretionary growth capital, supporting the expansion of MBody AI's commercial platform post-merger, thereby enhancing the company's financial flexibility and strategic execution capabilities.
- Enhanced Financial Transparency: Check-Cap furnished MBody AI's audited financial statements for 2024, indicating significant growth in customer deployments in the second half of 2025, suggesting the company is entering a new phase of commercial scaling with potential for increased customer engagement.
- Leadership Confidence: Executives from both Check-Cap and MBody AI expressed that the merger will establish a leadership position in the physical AI sector, expected to attract public market investors' attention and further drive industry development.
See More
- Merger Progress: Check-Cap has received written confirmation from Nasdaq indicating compliance with listing rules, paving the way for its merger with MBody AI, which is expected to significantly enhance the company's market position.
- Shareholder Support: At the November annual meeting, 98.01% of votes favored the merger with MBody AI, demonstrating strong investor confidence in this strategic move, which may attract more investor interest.
- Stock Surge: Following the merger announcement, Check-Cap's shares surged nearly 100% on Monday, reflecting market optimism about the merger's prospects and potentially increasing the company's appeal in capital markets.
- Business Restructuring: Post-merger, Check-Cap will be renamed “MBody AI Ltd.”, and this rebranding will help the company establish a stronger market presence in the rapidly evolving AI sector, driving future business growth.
See More
- Compliance Regained: Check-Cap Ltd. has received written confirmation from the Nasdaq Listing Qualifications Department that it has regained compliance with Nasdaq's minimum shareholders' equity requirements, establishing a crucial foundation for its merger with MBody AI.
- Merger Progress: The merger received approximately 98% shareholder approval and is expected to transform Check-Cap into a publicly traded leader in embodied artificial intelligence, further enhancing its position in the rapidly growing AI market.
- Technology Platform Advantage: MBody AI's MBody AI Orchestrator™ platform is already deployed across robotic systems at multiple Fortune 500 companies, delivering real-time data intelligence and AI-driven performance insights, thereby strengthening Check-Cap's competitive edge in the market.
- Leadership Outlook: Both Check-Cap and MBody AI leadership expressed that the confirmation of compliance provides strong support for the final stages of the merger, indicating that the company is poised to play a significant role in future technological transformations.
See More









